NYSE$K

Kellanova · Q4 2020 earnings

Q4 2020 earnings · · Investor relations

Briefing

Kellogg Company reported strong Q4 2020 results, driven by net sales growth and disciplined execution.

Kellogg Company announced strong fourth quarter and full year 2020 results, with net sales increasing on both a reported and organic basis. The company issued 2021 financial guidance that implies growth on a two-year basis.

  • Kellogg executed well against its priorities of ensuring employees' health and safety, supplying food to the marketplace, and aiding its communities.
  • The company finished the year with results that were on or better than its guidance for each of its key metrics.
  • Kellogg delivered fourth quarter and full year net sales growth on a reported and organic basis, underpinned by strong in-market performance.
  • The company generated better-than-expected cash from operating activities in 2020, enabling it to reduce its debt for greater financial flexibility.

Headline financials

Total Revenue

$3.46B

Previous: $3.22B+7.5%
EPS (adj)

$0.86

Previous: $0.91-5.5%
Organic revenue growth

2.5%

Previous: 2.7%-7.4%
Net Income

$208M

Previous: $152M+36.8%
Operating Income

$385M

Previous: $360M+6.9%
Cash & Equivalents

$435M

Previous: $397M+9.6%
Total Assets

$18B

Previous: $17.6B+2.5%

Revenue & EPS history

Kellanova · Revenue · Quarterly

$3.46B

Q4 2020+7.5%vs Q4 2019
Beat estimate in 14 of 16 quarters(88%)
ActualEstimate

Revenue by segment

Kellanova · $3.47B total across 4 segments · Q4 2020

  • North America
    $2.04B+7.6%
  • Europe
    $608M+15.6%
  • AMEA
    $590M+3.5%
  • Latin America
    $229M-1.7%

Forward guidance

The Company issued its initial financial guidance for 2021. Specifically, the Company is projecting organic net sales to decrease by approximately (1)%, adjusted operating profit on a currency-neutral basis is expected to decline by approximately (2)%, and adjusted earnings per share, on a currency-neutral basis, is expected to increase by approximately 1%.

Tailwinds

  • Organic net sales to decrease by approximately (1)%, as it compares against unusually strong, COVID-related growth in the prior year; this implies a 2-year compound annual growth of about 2.5%.
  • Adjusted operating profit on a currency-neutral basis is expected to decline by approximately (2)%, as it compares against unusually strong, COVID-related growth and a 53rd week in the prior year; this implies a 2-year compound annual growth of 3-4%, after excluding the profit of since-divested businesses from the 2019 base.
  • Adjusted earnings per share, on a currency-neutral basis, is expected to increase by approximately 1%; this implies a 2-year compound annual growth of 4-5% after excluding the profit of since-divested businesses from the 2019 base.
  • Net cash provided by operating activities is expected to be approximately $1.6 billion, with capital expenditure of about $0.5 billion.
  • Cash flow is expected to be approximately $1.1 billion.

Headwinds

  • Organic net sales to decrease by approximately (1)%, as it compares against unusually strong, COVID-related growth in the prior year.
  • Adjusted operating profit on a currency-neutral basis is expected to decline by approximately (2)%, as it compares against unusually strong, COVID-related growth and a 53rd week in the prior year.
  • Adjusted earnings per share, on a currency-neutral basis, is expected to increase by approximately 1%.
  • Excluded from this guidance, are any significant supply chain or other prolonged market disruptions related to the pandemic or global economy.
  • Guidance for operating profit excludes the impact of costs related to restructuring programs, mark-to-market adjustments, multi-employer pension plan exit liabilities, and other items that could affect comparability, and foreign currency translation.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 15 quarterly earnings reports

Historical avg

+0.6%

Avg return

Earnings day

+2.4%

Avg return

5 days after

+1.4%

Avg return

30 days after

49%

33 / 67 earnings

Positive

+8.9%

Q2 2019

Best reaction

-10.9%

Q3 2018

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026
Q4 2025
Q3 2025+0.1%+0.2%+0.7%
Q2 2025-0.0%-0.1%-0.4%
Q1 2025-0.0%-0.9%-0.6%
Q4 2024+0.3%+0.4%+0.7%
Q3 2024-0.3%+0.0%+0.3%
Q2 2024+8.3%+26.1%+38.3%
Q1 2024+6.2%+8.2%+5.8%
Q4 2023-0.4%+1.0%+1.0%
Q3 2023+2.2%+2.6%+5.5%
Q2 2023-2.8%-4.8%-10.2%
Q1 2023-1.7%-1.5%-5.8%
Q4 2022+0.7%-0.0%-5.0%
Q3 2022-7.9%-5.8%-2.6%
Q2 2022+1.5%+1.7%-1.7%
Q1 2022+7.2%+7.5%-0.2%
Q4 2021+3.5%+4.6%-3.1%
Q3 2021-1.2%
Q2 2021+1.9%
Q1 2021+6.2%
Q4 2020-1.3%
Q3 2020-0.9%
Q2 2020-2.7%
Q1 2020-0.1%
Q4 2019-7.5%
Q3 2019+4.6%
Q2 2019+8.9%
Q1 2019-4.9%
Q4 2018-6.4%
Q3 2018-10.9%
Q2 2018+3.9%
Q1 2018+5.5%
Q4 2017+4.9%
Q3 2017+7.0%
Q2 2017+3.2%
Q1 2017+2.5%
Q4 2016+3.4%
Q3 2016-0.1%
Q2 2016+2.0%
Q1 2016-2.6%
Q4 2015+5.8%
Q3 2015-2.7%
Q2 2015+3.9%
Q1 2015-1.8%
Q4 2014-4.7%
Q3 2014+2.4%
Q2 2014-3.6%
Q1 2014-1.8%
Q4 2013+1.7%
Q3 2013+1.3%
Q2 2013-1.5%
Q1 2013-1.5%
Q4 2012+1.5%
Q4 2011+2.0%
Q3 2012+2.6%
Q2 2012+5.3%
Q1 2012-0.3%
Q3 2011-1.0%
Q2 2011-1.4%
Q1 2011-0.4%
Q1 2010+1.0%
Q4 2007-0.3%
Q4 2010-0.3%
Q3 2009+0.8%
Q3 2010+0.8%
Q2 2010-0.1%
Q4 2009-0.1%
Q2 2009-0.1%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro